U.S. law firm Morrison Foerster has advised Japan’s Kyowa Kirin on its $477.6 million acquisition of British biopharmaceutical company Orchard Therapeutics, which was represented by Goodwin Procter. Slaughter & May was Orchard’s UK legal advisor.

Reuters quoted Kyowa as saying that the acquisition has already been cleared by the two firms' boards of directors but required approval by the British company's shareholders. The deal is expected to be completed in the first quarter of 2024.

The Morrison Foerster team advising Kyowa Kirin on the deal was led by partner Gary Smith in Tokyo, with support from partners Masato Hayakawa in Tokyo and Joe Sulzbach in New York.

The Goodwin life sciences and M&A teams that represented Orchard on the transaction were led by partners Michael Bison, Jim Matarese, Andrew Goodman, and Tevia Pollard.



Related Articles

PAG GC to join MoFo Tokyo as partner

Morrison & Foerster is set to boost its private equity and M&A practices in Asia with the hire of veteran corporate lawyer Gregory Salathé as a partner in Tokyo. Salathé will join the firm in September from investment manager PAG, where he is currently a partner and group general counsel.

Japan’s Isshiki bolsters IP litigation offering with ex-judge, MoFo hires

by Mari Iwata |

Japanese boutique firm Isshiki & Partners has strengthened its intellectual property litigation capabilities with the addition of two new partners: Yukio Nagasawa, a former IP judge, and Akira Irie, a litigator from Morrison & Foerster.

Latham taps rival MoFo for M&A partner in Tokyo

by Nimitt Dixit |

Global law firm Latham & Watkins has turned to U.S. rival Morrison & Foerster to bolster its M&A capabilities in Japan with the hire of deals and private equity partner Yohei Nakagawa in Tokyo.